Connect with us

Headlines

Johnson & Johnson Vision Gets New Chairman

He previously was worldwide president for the company’s Vision Care division.

mm

Published

on

Johnson & Johnson Vision announced the appointment of Peter Menziuso as company group chairman.

Menziuso now leads the full Johnson & Johnson Vision portfolio, including brands such as Acuvue contact lenses, Tecnis family of intraocular lenses and TearScience LipiFlow.

“Peter’s breadth of experience and passion for eye health position him well to lead J&J Vision,” said Ashley McEvoy, executive vice president, worldwide chairman, Johnson & Johnson MedTech. “Peter has built a reputation as a purpose-driven, highly successful global leader, with a deep focus on innovation in service of healthcare professionals and patients.”

Throughout his career of more than 30 years at Johnson & Johnson, Menziuso “has accelerated businesses to high growth by articulating a compelling vision and strategy, building high-performing teams, and strengthening accountability,” according to the release. Menziuso has spent half of his career in roles outside of the U.S. and has deep experience across the healthcare industry, pharmaceutical, biotech and medical devices in a variety of therapeutic areas.

Prior to his appointment as company group chairman, Menziuso was worldwide president for the company’s Vision Care division. In this role, he “created and raised standards of eye care around the world and shaped a portfolio of meaningful solutions to deliver healthy sight for life,” according to the release. He also previously served as U.S. president for vision care.

“We largely intuit life through sight — it’s how we learn, engage, connect. Across my career with Johnson & Johnson, what has fueled me has been the transformational effect we have on people’s lives on such a large scale—that focus continues,” said Menziuso. “As the only eye care company with health at its core as part of Johnson & Johnson, and with a heritage of innovation ‘firsts’, we have the unique opportunity to not just imagine what the future of eye health looks like, but to redefine it.“

Advertisement

Mr. Menziuso has also served as president, North America, cardiovascular and metabolism, Janssen. His earlier roles within Johnson & Johnson included vice president, worldwide marketing; vice president, U.S. sales and market development; and general manager, Canada, for LifeScan.

SPONSORED VIDEO

SPONSORED BY VARILUX

The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines

Advertisement

Advertisement

Subscribe

INVISIONMAG.COM
BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Advertisement

Most Popular